The global life sciences industry is advancing rapidly. Increased generic competition, the changing patent landscape, evolving regulations, and pricing pressures present new challenges and opportunities for companies across the sector.
Our cross-disciplinary team can steer you through every phase of your life cycle, helping you carefully consider all of your options, and execute effective growth strategies—whether through licensing, M&A deals, or other types of transactions.
And while we have a lot of experience with transactions and litigation for large public companies, we have a passion for helping mid-market and startup companies grow.
The rapidly changing life sciences ecosystem presents a lot of exciting opportunities. We’re focused on helping clients leverage those opportunities and make strategic decisions that maximize their business potential.
Los Angeles Daily Journal | October 10, 2017
Los Angeles IP litigation partner Shawn Hansen is quoted in this article about drug maker Amgen Inc.’s request for a federal judge to invalidate patents claimed by a rival company so it can create a generic, less expensive version of a popular cancer drug.
Los Angeles/San Francisco Daily Journal | February 15, 2017
Los Angeles IP litigation partner Shawn Hansen authored this column about an upcoming case in the U.S. Supreme Court that will deal with Biologics Price Competition and Innovation Act of 2009 (BPCIA), which was enacted as part of the Affordable Care Act (ACA).
Long Island Business News | January 11, 2017
Long Island office managing partner Allan Cohen provides an outlook on industries such as life sciences and biotechnology which have been areas of recent growth for Long Island.
Law360 | July 13, 2016
Boston Government Investigations & White Collar Defense partner Brian French, a member of the Life Sciences team, is quoted in this story looking at important cases the industry is monitoring for the remainder of the calendar year. Brian is quoted discussing False Claims Act matters.
Los Angeles Business Journal | June 22, 2015
This article focuses on a new $250 million independent fund created by the University of California to invest in research enterprises on its campuses. Los Angeles IP Counseling & Transactions partner Seth Levy talks about the research environment particularly for health care technologies and how it’s changed with regard to what it takes to get technology licensed or spun out.
Cannabis Alert | 04.23.18
Patent Law Alert | 02.23.18
Patent Alert | 12.13.17
Environmental Law Alert | 11.09.17
Patent Alert | 09.11.17
Patent Alert | 08.02.17
Patent Alert | 06.26.17
Patent Law Alert | 05.19.17
Patent Law Alert | 04.26.17
02.22.18 | Chicago, IL
11.07.17 | Webinar
06.01.17 | Boston, MA
10.07.15 | Los Angeles, CA
06.16.15 | Los Angeles, CA